Calendar Cocrystal Pharma, Inc.

Equities

COCP

US19188J4094

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.555 USD +2.98% Intraday chart for Cocrystal Pharma, Inc. +1.64% -9.71%

Chart calendar Cocrystal Pharma, Inc.

ee63406.hmIdofVskofZNbHy7ITqko5TXR9-GJPXS-R47R45uTg.7Bh84IRV9-K7Q4e53bGI5rpnaE4EYOGaDJMyskxU2gnoPVbQsTbjwagA8A~0856bf787f4b07c4a5dfde3bd488f417

Upcoming events on Cocrystal Pharma, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-04-06 Q4 2024 Earnings Release (Projected)

Past events on Cocrystal Pharma, Inc.

2024-03-28 08:00 am Q4 2023 Earnings Release
2023-12-04 01:30 pm Noble Capital Markets Emerging Growth Equity Conference
2023-11-26 World Vaccine Congress
2023-11-15 Channelchek C-Suite Interview Series
2023-11-13 08:00 am Q3 2023 Earnings Release
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-14 08:00 am Q2 2023 Earnings Release
2023-06-08 02:00 pm Annual General Meeting
2023-05-15 08:00 am Q1 2023 Earnings Release
2023-05-04 02:05 pm International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Conference
2023-03-29 10:30 am Investor Summit
2023-03-29 08:00 am Q4 2022 Earnings Release
2023-02-02 11:30 am Sequire Biotechnology Conference
2023-01-31 Channelchek Takeaway Series - The J.P.Morgan Healthcare Conference
2022-12-01 11:10 am World Antiviral Congress
2022-11-14 11:30 am FY Investor Summit
2022-11-14 08:00 am Q3 2022 Earnings Release
2022-11-03 02:05 pm BioFlorida Conference
2022-10-26 06:30 pm LD Micro Main Event Conference
2022-10-12 01:00 pm Dawson James Small Cap Growth Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
2,01
2,08
-3.06%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
-19,7
-

-20,6

EBIT
Million USD
Released
Forecast
Spread
-8,87
-9,14
3.02%
-9,59
-11,0
13.13%
-14,2
-14,4
1.37%
-38,8
-40,1
3.23%
-18,6
-19,8
6.07%

-23,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-14,2
-14,4
1.49%
-38,8
-40,1
3.24%
-18,0
-19,2
6.55%

-23,5

Net income
Million USD
Released
Forecast
Spread
-48,2
-6,19
-678.43%
-9,65
-10,7
9.83%
-14,2
-14,4
1.49%
-38,8
-40,1
3.24%
-18,0
-19,2
6.55%

-23,5

EPS
USD
Released
Forecast
Spread
-18,1
-2,28
-694.74%
-2,04
-2,40
15%
-1,92
-1,92
0%
-4,77
-4,93
3.25%
-1,87
-2,09
10.67%

-2,30

Announcement Date27/03/2017/03/2123/03/2229/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,63
-
0,00
0,08
-
0,00
0,08
-
0,00
0,00
-
0,00
0,17
-
0,00
0,27
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00




EBIT
Million USD
Released
Forecast
Spread
-3,70
-3,90
5.08%
-4,21
-3,50
-20.14%
-3,74
-4,20
11.05%
-5,69
-4,10
-38.88%
-4,50
-5,80
22.38%
-5,11
-4,50
-13.58%
-5,20
-5,30
1.91%
-4,44
-4,60
3.41%
-4,67
-5,88
20.65%

-5,55


-5,80


-6,05


-6,25




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,69
-3,90
5.51%
-4,21
-3,50
-20.23%
-24,4
-4,20
-481.62%
-5,70
-4,10
-39.02%
-4,50
-5,80
22.4%
-5,19
-4,50
-15.31%
-5,03
-5,30
5.17%
-4,17
-4,60
9.46%
-4,46
-5,88
24.08%

-5,50


-5,75


-6,00


-6,20




Net income
Million USD
Released
Forecast
Spread
-3,69
-3,90
5.51%
-4,21
-3,50
-20.23%
-24,4
-4,20
-481.62%
-5,70
-4,10
-39.02%
-4,50
-5,80
22.4%
-5,19
-4,50
-15.31%
-5,03
-5,30
5.17%
-4,17
-4,60
9.46%
-4,46
-5,88
24.08%

-5,50


-5,75


-6,00


-6,20




EPS
USD
Released
Forecast
Spread
-0,48
-0,48
0%
-0,48
-0,48
0%
-3,00
-0,54
-455.56%
-0,70
-0,49
-42.86%
-0,54
-0,71
23.94%
-0,64
-0,59
-8.47%
-0,50
-0,53
4.76%
-0,41
-0,53
22.64%
-0,44
-0,60
26.26%

-0,54


-0,57


-0,59


-0,61


-0,49

Announcement Date23/03/2211/05/2215/08/2214/11/2229/03/2315/05/2314/08/2313/11/2328/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. COCP Stock
  4. Calendar Cocrystal Pharma, Inc.